Introduction: Choice of insertion side and patient position during continuous renal replacement therapy (CRRT) with femoral vein vascular access may affect circuit life. We investigated if there is an association between choice of insertion side and body position and its changes and circuit life during CRRT with femoral vein access. Methods: We studied 50 patients receiving CRRT via femoral vein access with a sequential retrospective study in a tertiary intensive care unit. We defined two groups: patients with right or left femoral vein access. We then obtained information on age, gender, circuit life, total heparin dose, hemoglobin concentration and coagulation variables (platelet count, international normalized ratio, and activated partial thromboplastin time) and percentage of time each patient spent in the supine, left lying, right lying, and sitting position during treatment. Results: We studied 341 circuits in 50 patients. Mean circuit life was 13.9 h. Of these circuits, 251 (73.6%) were treated with right femoral vein access. Mean circuit life in this group was significantly longer compared with left femoral vein access (15.0 ± 14.3 vs. 10.6 ± 7.4; p = 0.019). Percentage spent in a particular position during CRRT was not significantly different between two groups. On multivariable linear regression analysis, mean circuit life was significantly and positively correlated with right vascular access site (p = 0.03) and lower platelet count (p = 0.03), but not with patient position. Conclusions: Right-sided insertion but not time spent in a particular position significantly affects circuit life during CRRT with femoral vein access.

Keywords:
Continuous renal replacement therapy, Femoral vein access, Circuit life, Insertion side
1.
Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum J: Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007;33:1563–1570.
2.
Vanholder R, Van Biesen W, Lameire N: What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephrol 2001;12:S40–S43.
3.
Ronco C, Cruz D, Bellomo R: Continuous renal replacement therapy in critical illness. Contrib Nephrol 2007;156:309–319.
4.
Baldwin I: Factors affecting circuit patency and circuit life. Contrib Nephrol 2007;156:178–184.
5.
Baldwin I, Fealy N: Nursing for renal replacement therapies in the intensive care unit: historical, educational and protocol review. Blood Purif 2009;27:174–181.
6.
Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Continuous is not continuous: the incidence and impact of circuit and ‘down time’ on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003;29:575–578.
7.
Fealy N, Baldwin I, Bellomo R: The effect of circuit ‘down time’ on uraemic control during continuous veno-venous haemofiltration. Crit Care Resus 2002;4:266–270.
8.
The RENAL Study Investigators: Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med 2009;361:1627–1638.
9.
Schiffl H, Lang S, Fischer R: Daily dialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305–310.
10.
Parienti JJ, Mégarbane B, Fischer MO, Lautrette A, Gazui N, Marin N, Hanouz JL, Ramakers M, Daubin C, Mira JP, Charbonneau P, du Cheyron D, Cathedia Study Group: Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med 2010;38:1118–1125.
11.
Parienti JJ, Thirion M, Mégarbane B, Souweine B, Ouchikhe A, Polito A, Forel JM, Marqué S, Misset B, Airapetian N, Daurel C, Mira JP, Ramakers M, du Cheyron D, Le Coutour X, Daubin C, Charbonneau P, Members of the Cathedia Study Group: Femoral vs. jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008;299:2413–2422.
12.
Baldwin I, Bellomo R: Relationship between blood flow, access catheter and circuit failure during CRRT: a practical review. Contrib Nephrol 2004;144:203–213.
13.
Kim IB, Fealy N, Baldwin I, Bellomo R: Premature circuit clotting due to likely mechanical failure during continuous renal replacement therapy. Blood Purif 2010;30:79–83.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.